These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8314640)

  • 21. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
    Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE
    Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of glutaraldehyde-crosslinked chitosan as a scaffold for hepatocyte attachment.
    Kawase M; Michibayashi N; Nakashima Y; Kurikawa N; Yagi K; Mizoguchi T
    Biol Pharm Bull; 1997 Jun; 20(6):708-10. PubMed ID: 9212997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].
    Ju WQ; He XS; Wang DP; Deng RH; Wu LW; Guo ZY; Zhu XF; Huang JF
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):14-6. PubMed ID: 22464699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation.
    Gupta S; Aragona E; Vemuru RP; Bhargava KK; Burk RD; Chowdhury JR
    Hepatology; 1991 Jul; 14(1):144-9. PubMed ID: 2066062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term correction of genetic defect of liver function in rat by transplantation of liver cells after ultraviolet irradiation.
    Patel A; Hardy MA; Chowdhury NR; Wajsman R; Sandoval M; Wilson JM; Chowdhury JR
    Mol Biol Med; 1989 Apr; 6(2):187-96. PubMed ID: 2615646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrasplenic transplantation of encapsulated cells: a novel approach to cell therapy.
    Aoki T; Umehara Y; Ferraresso C; Sugiyama N; Middleton Y; Avital I; Inderbitzin D; Demetriou AA; Rozga J
    Cell Transplant; 2002; 11(6):553-61. PubMed ID: 12428745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(vinyl alcohol) synthetic polymer foams as scaffolds for cell encapsulation.
    Li RH; White M; Williams S; Hazlett T
    J Biomater Sci Polym Ed; 1998; 9(3):239-58. PubMed ID: 9556760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B.
    Lo CM; Fung JT; Lau GK; Liu CL; Cheung ST; Lai CL; Fan ST; Wong J
    Hepatology; 2003 Jan; 37(1):36-43. PubMed ID: 12500186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow-derived stem cells and hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Barone M; Scavo MP; Maiorano E; Di Leo A; Francavilla A
    Dig Liver Dis; 2014 Mar; 46(3):243-50. PubMed ID: 24286758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hollow fibers for hepatocyte encapsulation and transplantation: studies of survival and function in rats.
    Yang MB; Vacanti JP; Ingber DE
    Cell Transplant; 1994; 3(5):373-85. PubMed ID: 7827775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
    Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
    Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hepatocyte transplantation: contribution of Fas-Fas ligand interaction to allogeneic hepatocyte rejection.
    Kawahara T; Yagita H; Kasai S; Sawa M; Kato K; Okumura K; Futagawa S; Mito M
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S119-23. PubMed ID: 9792045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation of encapsulated hepatocytes during acute liver failure improves survival without stimulating native liver regeneration.
    Sgroi A; Mai G; Morel P; Baertschiger RM; Gonelle-Gispert C; Serre-Beinier V; Buhler LH
    Cell Transplant; 2011; 20(11-12):1791-803. PubMed ID: 21396154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
    Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.